Juvenal Tobin W has filed a Form 144 to sell 3,195 shares of Castle Biosciences, Inc. This filing, submitted on November 12, 2026, highlights a significant insider transaction that may influence market perceptions of the company.

Castle Biosciences, Inc. operates in the medical laboratories sector, providing diagnostic and prognostic tests to enhance patient care. The company is incorporated in Delaware and has its business address at 1500 W. Parkwood Ave., Suite 400, Friendswood, TX. It trades on the NASDAQ under the SEC file number 001-38984.

According to the filing, Tobin exercised stock options to acquire the shares on November 11, 2026, and the transaction was conducted for cash. The aggregate market value of the shares sold is approximately $112,032.68. The filing also notes that Tobin has sold a total of 13,154 shares on November 9, 2026, generating gross proceeds of $452,234.52, along with several other transactions in the preceding months.

This transaction may affect investor sentiment and the stock's performance, particularly as insider sales can be viewed as a signal regarding the company's future prospects. The medical laboratories industry is particularly sensitive to such developments, as they can influence investor confidence and market dynamics.

Details were not available in the SEC filing regarding any upcoming events or further actions following this transaction.